Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study
Year: 2010
Type: article
Source: European Journal Of Haematology
Institutions: National and Kapodistrian University of Athens, Consejo Superior de Investigaciones Científicas, Universidad de Salamanca, Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer de Salamanca, Dana-Farber Cancer Institute, Botkin Hospital, City Clinical Hospital, Rabin Medical Center, University of Münster, University of Turin, Belgian Hematological Society, Takeda Oncology (United States), Janssen Research & Development (United States), Johnson & Johnson (United Kingdom)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1952760452
